Abstract:Institutions: STONY BROOK MEDICAL CENTERRATIONALE: Lung Cancer screening for the high-risk smoking population has been proven to save lives. However, in 2022, 20% of newly diagnosed lung cancers (47,300) were in nonsmokers. These patients were found to be diagnosed at later stages. This may be at least partly due to not meeting criteria for and participating in current lung cancer screening. This study aims to describe characteristics of a never smoker patient population to help identify common risk factors which might merit inclusion in lung cancer screening and thus improve patient outcomes. Methods: This retrospective single center study included never-smoker patients diagnosed with lung nodules and never-smoker patients diagnosed with lung cancer from 2016 to 2022. Data was obtained from the Stony Brook Medical Center electronic medical record. 16,056 patients were identified as never-smokers who were asked by the medical assistant if they ever smoked in their lifetime. Patients were eliminated if they had any smoking history up to first diagnosis date. Demographics, radiology, histology, diagnosis dates, comorbidities, smoking status, and exposures collected through ICD10 codes and not self-reported, were investigated. Results: Of 16,056 never-smoking patients, 9315 (58.02%) were females diagnosed with lung nodules and 6741 (41.98%) were males diagnosed with lung nodules. The univariate analysis showed significant differences between gender, age at nodule diagnosis, and patients with and without comorbidities including chronic obstructive pulmonary disease (COPD), hypertension (HTN), and family history (FHX) of lung cancer. The percentage of lung cancer patients among females was significantly higher than among males. Patients having lung cancer were older. The percentages of lung cancer patients with these comorbidities were significantly higher than those without. However, there was no significant difference found between patients with and without diabetes mellitus (DM). The multivariable logistic regression suggested that age at nodule diagnosis and comorbidities including COPD (which included asthma, emphysema and chronic bronchitis) and family history of lung cancer were significantly associated with lung cancer. Older patients and patients with those comorbidities had a higher risk of developing cancer than those who were younger or without those comorbidities. The study excluded HTN and included age at nodule diagnosis in the logistic regression model as HTN was found to be protective against lung cancer due to age at lung nodule diagnosis. Please refer to the appendix for further details. Conclusion: Never-smoker patients who were older and with COPD and Family History of lung cancer had higher risk of developing lung cancer than younger patients without these comorbidities. In this study, gender had no impact on outcome.

1.2 Cm Lung Nodule Developed into Metastatic Lung Adenocarcinoma in Two Years in Patient Low Socioeconomic Status

The Pulmonary Nodule "discovered" by Pneumonia: a Case Report.

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years

Analysis of risk factors for stage I lung adenocarcinoma using low-dose high-resolution computed tomography.

Evaluating the Patient With a Pulmonary Nodule: A Review

Multivariate Analysis on Development of Lung Adenocarcinoma Lesion from Solitary Pulmonary Nodule

Incidental Pulmonary Nodules: Differential Diagnosis and Clinical Management

Risk Analyses of N2 Lymph-Node Metastases in Patients with T1 Non-Small Cell Lung Cancer: a Multi-Center Real-World Observational Study in China

Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients

[Clinical Characteristics and Prognosis of Sub-centimeter Lung Adenocarcinoma].

[The pulmonary nodule: from incidental finding to pathological confirmation]

Lung Adenocarcinoma Manifested as Ground Glass Nodules in Teenagers: Characteristics, Surgical Outcomes, and Management Strategies

The effect of median household income on the prognosis of lung adenocarcinoma—A SEER analysis

[Prognosis Factors Analysis of Patients with Malignant Solitary Pulmonary Nodules].

Evaluation of the solitary pulmonary nodule

Management Of Indeterminate Pulmonary Nodules (< 1 Cm) Newly Detected During The Follow-Up Of Nasopharyngeal Carcinoma Patients

Factors associated with delays in care of suspicious lung nodules at an academic medical center.

Solitary pulmonary nodule in an early adolescent

Lung cancer in nonsmokers- A risk factor analysis

The Value of Pulmonary Nodule Diameter and Consolidation/tumor Rate in the Prediction of Lymph Node Metastasis in Early-Stage (ct1n0m0) Lung Adenocarcinoma.